Clinical Trial Update: Evaluation of Target Organs Damage in Hypertensive Patients

View source ↗

Summary

AstraZeneca-sponsored trial evaluating target organ damage in patients with hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: AstraZeneca | Conditions: Target Organs Damage, Hypertensive | Status: COMPLETED